IMIPENEM ANHYDROUS

SynDRA canonical compound SYN0001776 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Mechanism of action	bacterial cell wall synthesis inhibitor
Indication	bacterial septicemia \| bone and joint infections \| endocarditis \| gynecologic infections \| intra-abdominal infections \| pneumonia \| skin infections \| urinary tract infections
Disease area	infectious disease

All known targets

imipenem
tienamycin
imipemide
imipenen
imipenem hydrate
Imipenem (anhydrous)
Imipenem
Imipemide
Tienamycin
Imipenem (INN)
N-Formimidoylthienamycin
Primaxin (TN)
Imipenem, N-Formimidoyl thienamycin
[5R-[5.alpha.,6.alpha.(R*)]]-6-(1-Hydroxyethyl)-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid monohydrate
(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure
(5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl}thio)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
MK-0787
imipenem monohydrate (usp-rs)
IMIPENEM
Imipenem hydrate
Imipenem, Anhydrous
Anhydrous Imipenem
Imipenem monohydrate
imipenem (usp monograph)
RECARBRIO COMPONENT IMIPENEM
Imipenem monohydrate (h2o)
PRIMAXIN COMPONENT IMIPENEM
IMIPENEM ANHYDRATE
imipenem monohydrate (ep monograph)
Q20IM7HE75
NSC 759901
N Formimidoylthienamycin
Imipenemum
N-formimidoyl thienamycin
CHEBI:471744
DTXCID903143
MK0787